Cold Start Therapeutics

Meliora Therapeutics

This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

Noetik

This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.

Cellemedy

The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.